| Recruiting | Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED). Dry Eye Disease | Phase 2 | 2025-11-03 |
| Withdrawn | FIB Grifols Congenital Deficiency for On-demand Treatment and Surgical Prophylaxis Congenital Afibrinogenemia, Hypofibrinogenemia | Phase 3 | 2023-12-01 |
| Completed | Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19 COVID-19 | Phase 2 | 2020-07-29 |
| Completed | Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Dise COVID-19 | Phase 2 | 2020-06-02 |
| Completed | A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recove COVID-19 | Phase 2 | 2020-04-29 |
| Completed | A Study of Safety and Efficacy of Fibrin Sealant Grifols as an Adjunct to Haemostasis During Surgery in Paedia Excessive Bleeding During Surgery | Phase 3 | 2019-01-18 |
| Completed | Efficacy and Safety of Plasma Exchange With Albumin in Patients With Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis | Phase 2 | 2014-11-01 |
| Terminated | Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% Dual Inactivation and F Post-polio Syndrome | Phase 2 / Phase 3 | 2014-09-23 |
| Completed | Safety and Efficacy of Topical Thrombin (Human) Grifols as an Adjunct to Hemostasis During Surgery Hemostasis | Phase 2 | 2013-12-01 |
| Completed | Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Parenchymous Tissue Open Surgeries Parenchymous Tissue Surgical Bleeding | Phase 3 | 2013-03-01 |
| Completed | Safety and Efficacy Study of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Peripheral Vascular Sur Vascular Surgical Bleeding | Phase 3 | 2012-08-01 |
| Completed | A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease Alzheimer's Disease | Phase 2 / Phase 3 | 2012-04-19 |
| Completed | Effects on Plasma Exchange on Functional Capacity of Serum Albumin, Circulatory Dysfunction, Renal and Cerebra Liver Cirrhosis, Liver Failure | N/A | 2011-03-01 |
| Completed | Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver T Hepatitis B, Liver Transplantation | Phase 3 | 2010-07-01 |
| Completed | Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites. Cirrhosis, Ascites | Phase 4 | 2009-07-01 |
| Completed | Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass Acquired Antithrombin III Deficiency, Coronary Artery Bypass | Phase 2 | 2009-06-01 |
| Completed | Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects Primary Immune Deficiency Disease | Phase 4 | 2008-05-01 |
| Completed | Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis Target Bleeding Site During Peripheral Vascular Surgery | Phase 2 / Phase 3 | 2008-02-01 |
| Completed | Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic Purpura Immune (Idiopathic) Thrombocytopenic Purpura | Phase 3 | 2008-02-01 |
| Completed | Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fl Alzheimer's Disease | Phase 2 | 2007-07-01 |
| Completed | Efficacy and Safety of Intramuscular HBIG Grifols for the Prevention of Recurrence After Liver Transplantation Hepatitis B, Chronic | Phase 2 | 2004-11-01 |
| Completed | Evaluation of Serum Levels and Pharmacokinetics of a New Hepatitis B Immune Globulin Following Liver Transplan Hepatitis B, Chronic | Phase 3 | 2003-10-01 |